NCT03087838 is a clinical trial in Intensive Care, sponsored by Capital Medical University.

Who is sponsoring NCT03087838?

NCT03087838 is sponsored by Capital Medical University.

What condition does NCT03087838 study?

NCT03087838 studies Intensive Care, Surgical, Postoperative Care, Neurosurgery.

Is NCT03087838 still recruiting?

NCT03087838 is currently completed. Last updated 12 February 2018.

Last reviewed 2018-02-12 · How we verify

NCT03087838

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postoperative Delirium in Adult Patients After Elective Craniotomy Under General Anaesthesia

Completed Last updated 12 February 2018

What this trial tests

trial in Intensive Care in 800 participants. Completed in 2 February 2018.

Timeline

1 March 2017

Primary endpoint
1 November 2017

2 February 2018

Quick facts

Lead sponsor	Capital Medical University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	800
Start date	1 March 2017
Primary completion	1 November 2017
Estimated completion	2 February 2018
Sites	1 location across China

Conditions studied

Intensive Care — all drugs for Intensive Care →
Surgical — all drugs for Surgical →
Postoperative Care — all drugs for Postoperative Care →
Neurosurgery — all drugs for Neurosurgery →

Sponsor

Capital Medical University

Who can join

18 and older, any sex, with Intensive Care or Surgical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative delirium may result in many adverse complications. At present little is known about postoperative delirium in patients after crniotomy because they may manifest similar symptoms to definitely delirium for some structural brain disease. Objective of this study is to find out incidence and risk factors of postoperative delirium in patients after elective craniotomy and also the relationship of postoperative delirium with clinical outcome.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Incidence and risk factors of postoperative delirium in patients admitted to the ICU after elective intracranial surgery: A prospective cohort study.
Wang CM, Huang HW, Wang YM, He X, et al · · 2020 · cited 44× · PMID 31464712 · DOI 10.1097/eja.0000000000001074
Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study.
Huang HW, Yan LM, Yang YL, He X, et al · · 2018 · cited 7× · PMID 30024979 · DOI 10.1371/journal.pone.0201064
Alteration of default mode network: association with executive dysfunction in frontal glioma patients.
Zhang X, Zhang G, Wang Y, Huang H, et al · · 2023 · cited 6× · PMID 36242576 · DOI 10.3171/2022.8.jns22591

Verify or expand the search:

Other recruiting trials for Intensive Care

Currently open trials in the same condition.

NCT06549374 — Kinetics of INF-γ Production in Intensive Care Patients · recruiting
NCT06716840 — Remimazolam Besylate in Sedation of Postcardioperative Patients · NA · recruiting
NCT06469970 — Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults · Phase 2 · recruiting
NCT06685367 — The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI) · NA · recruiting
NCT06532994 — Predictive Algorithms for Critical Rehabilitation Outcomes · recruiting

Other Capital Medical University trials

Trials by the same sponsor.

NCT07379437 — Haematococcus Pluvialis Astaxanthin for Brain Aging · NA · not yet recruiting
NCT07531394 — Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic St · Phase 3 · not yet recruiting
NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07513233 — Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) · Phase 1 · not yet recruiting
NCT07495358 — Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cance · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03087838 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Capital Medical University
Last refreshed: 12 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03087838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing